AITech Interview with Hanjo Kim, SVP of Global Strategy, Head of Medicinal Chemistry at Standigm
Much of the historical progress has been led by AI-native drug discovery companies that offer software or service to pharma players. And facilitating such services by one-of-a-kind organic chemists having expertise in molecular modeling combined with the knowledge of AI can only bring about disruption. So is this inspiring interview with Hanjo Kim, SVP of Global Strategy, Head of...